These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20476852)

  • 21. The effects of treating lower urinary tract symptoms on health-related quality of life: a short-term outcome.
    Quek KF; Loh CS; Low WY; Razack AH; Chua CB
    Singapore Med J; 2002 Aug; 43(8):391-8. PubMed ID: 12507023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One-third of the Swedish male population over 50 years of age suffers from lower urinary tract symptoms.
    Stranne J; Damber JE; Fall M; Hammarsten J; Knutson T; Peeker R
    Scand J Urol Nephrol; 2009; 43(3):199-205. PubMed ID: 19347773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enlarged prostate: a landmark national survey of its prevalence and impact on US men and their partners.
    Roehrborn CG; Marks L; Harkaway R
    Prostate Cancer Prostatic Dis; 2006; 9(1):30-4. PubMed ID: 16231014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of lower urinary tract symptoms on quality of life using Functional Assessment Cancer Therapy scale.
    Batista-Miranda JE; Molinuevo B; Pardo Y
    Urology; 2007 Feb; 69(2):285-8. PubMed ID: 17320665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
    Yang Y; Zhao XF; Li HZ; Wang W; Zhang Y; Xiao H; Zhang X
    Chin Med J (Engl); 2007 Mar; 120(5):370-4. PubMed ID: 17376305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
    Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
    Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High rate of prostate symptoms among Ariaal men from Northern Kenya.
    Campbell B
    Prostate; 2005 Jan; 62(1):83-90. PubMed ID: 15389807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sleep, arousal and health-related quality of life in men and women with coronary artery disease.
    Johansson A; Svanborg E; Swahn E; Ejdebäck J; Tygesen H; Edell-Gustafsson U
    J Clin Nurs; 2011 Oct; 20(19-20):2787-801. PubMed ID: 21781201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of lower urinary tract symptoms in men aged 45-79 years: a population-based study of 40 000 Swedish men.
    Andersson SO; Rashidkhani B; Karlberg L; Wolk A; Johansson JE
    BJU Int; 2004 Aug; 94(3):327-31. PubMed ID: 15291861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging.male (MSAM-7)].
    Rosen R; Altwein J; Boyle P; Kirby RS; Lukacs B; Meuleman E; O'Leary MP; Puppo P; Chris R; Giuliano F
    Prog Urol; 2004 Jun; 14(3):332-44. PubMed ID: 15373175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is well-being associated with lower urinary tract symptoms in patients with stroke?
    Tibaek S; Dehlendorff C; Iversen HK; Klarskov P; Gard G; Jensen R
    Scand J Urol Nephrol; 2011 Mar; 45(2):134-42. PubMed ID: 21250795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of lower urinary tract symptoms and comorbidities on quality of life: the BACH and UREPIK studies.
    Robertson C; Link CL; Onel E; Mazzetta C; Keech M; Hobbs R; Fourcade R; Kiemeney L; Lee C; Boyle P; McKinlay JB
    BJU Int; 2007 Feb; 99(2):347-54. PubMed ID: 17313423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
    Nishino Y; Masue T; Miwa K; Takahashi Y; Ishihara S; Deguchi T
    BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.
    Irwin DE; Milsom I; Kopp Z; Abrams P; Artibani W; Herschorn S
    Eur Urol; 2009 Jul; 56(1):14-20. PubMed ID: 19278775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Content validity of the Benign Prostatic Hyperplasia Impact Index (BII); a measure of how urinary trouble and problems associated with BPH may impact the patient.
    Kingery L; Martin ML; Naegeli AN; Khan S; Viktrup L
    Int J Clin Pract; 2012 Sep; 66(9):883-90. PubMed ID: 22897465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
    Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
    BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of symptomatic BPE among Malaysian men aged 50 and above attending screening during prostate health awareness campaign.
    Teh GC; Sahabudin RM; Lim TC; Chong WL; Woo S; Mohan M; Khairullah A; Abrams P
    Med J Malaysia; 2001 Jun; 56(2):186-95. PubMed ID: 11771079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moving towards a comprehensive assessment of lower urinary tract symptoms (LUTS).
    Coyne KS; Barsdorf AI; Thompson C; Ireland A; Milsom I; Chapple C; Kopp ZS; Bavendam T
    Neurourol Urodyn; 2012 Apr; 31(4):448-54. PubMed ID: 22396308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relation of lower urinary tract symptoms with life-style factors and objective measures of benign prostatic enlargement and obstruction: an Italian survey.
    Tubaro A; La Vecchia C;
    Eur Urol; 2004 Jun; 45(6):767-72. PubMed ID: 15149750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.